Skip to content

Effect of oral roxadustat on renal anemia after allogeneic kidney transplantation: an observational study

Effect of oral roxadustat on renal anemia after allogeneic kidney transplantation: an observational study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100048566
Enrollment
Unknown
Registered
2021-07-10
Start date
2021-10-01
Completion date
Unknown
Last updated
2022-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney transplant

Interventions

Case series:None

Sponsors

Renji Hospital affiliated to Shanghai Jiao Tong University Medical College
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.The study was nested within the renal transplant single patient database of Renji Hospital affiliated with Shanghai Jiao Tong University School of medicine, which contains clinical data and follow-up records of all recipients who underwent renal transplant surgery at our institution; 2.The study cohort was designed to prospectively select renal transplant recipients who underwent renal transplantation in our hospital from October 1, 2021, to October 31, 2022, with regular postoperative follow-up, and used oral roxastat capsules on medication prescription, to make up the renal anemia oral roxastat treatment cohort after renal transplantation.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
hemoglobin;

Countries

China

Contacts

Public ContactZhang Ming

Renji Hospital affiliated to Shanghai Jiao Tong University Medical College

15736875970@163.com+86 15618069970

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026